Relapsed Chronic Lymphocytic Leukemia
11 clinical trials · Condition
◉ Watch Relapsed Chronic Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia (NCT05246345) | University Hospital, Clermont-Ferrand | 2022-03-07 |
| Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (NCT03639324) | Virginia Commonwealth University | 2020-10-02 |
| Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas (NCT04305444) | Zhejiang DTRM Biopharma | 2020-04-24 |
| Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187) | H. Lee Moffitt Cancer Center and Research Institute | 2019-12-06 |
| UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668) | Masonic Cancer Center, University of Minnesota | 2017-05-15 |
| A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL (NCT01750567) | University of Michigan Rogel Cancer Center | 2012-11-01 |
Track Relapsed Chronic Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.